Live Breaking News & Updates on Nextgen Patient Self Scheduling
Stay updated with breaking news from Nextgen patient self scheduling. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kubient (NASDAQ:KBNT – Get Rating) and NextGen Healthcare (NASDAQ:NXGN – Get Rating) are both small-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, analyst recommendations, profitability, dividends and valuation. Analyst Recommendations This is a summary of current recommendations […] ....
NextGen Healthcare, Inc. (NASDAQ:NXGN – Get Rating) has been assigned an average rating of “Buy” from the eight brokerages that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, three have issued a buy rating and one has issued a […] ....
Equities research analysts expect NextGen Healthcare, Inc. (NASDAQ:NXGN – Get Rating) to post sales of $152.88 million for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for NextGen Healthcare’s earnings. The lowest sales estimate is $152.54 million and the highest is $153.50 million. NextGen Healthcare reported sales of $146.08 million in the […] ....
Equities research analysts forecast that NextGen Healthcare, Inc. (NASDAQ:NXGN – Get Rating) will announce $152.88 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for NextGen Healthcare’s earnings, with the lowest sales estimate coming in at $152.54 million and the highest estimate coming in at $153.50 million. NextGen […] ....
NextGen Healthcare (NASDAQ:NXGN – Get Rating) issued an update on its FY 2023 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $0.95-$1.01 for the period, compared to the consensus estimate of $0.99. The company issued revenue guidance of $628.00 million-$640.00 million, compared to the consensus revenue estimate of $627.02 […] ....